摘要 : Type 2 diabetes mellitus traditionally has been characterized by insulin resistance and ?cell dysfunction, leading to hyperglycemia and eventual micro- and macrovascular complications. Dipeptidyl peptidase-4 (DPP-4) inhibitors are... 展开
作者 | B. Joshua J. Neumiller FASCP Lindy Wood R. Keith Campbell |
---|---|
作者单位 | |
期刊名称 | 《Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 》 |
总页数 | 22 |
语种/中图分类号 | 英语 / R9 |
关键词 | alogliptin saxagliptin sitagliptin vildagliptin dipeptidyl peptidase-4 inhibitors DPP-4 incretin effect type 2 diabetes mellitus. |
馆藏号 | N2007EPST0001624 |